Ken Griffin acquired 126 Thousand Celldex Therapeutics shares worth $4.58 Million. That's 0.00% of their equity portfolio (1568th largest holding). The first Celldex Therapeutics trade was made in Q4 2019. Since then Ken Griffin bought shares nine more times and sold shares on six occasions. The stake costed the investor $4.24 Million, netting the investor a gain of 7.9% so far.